China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Multiomics mechanisms of treatmentresponse heterogeneity in T2DM-MASLD'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133229
Registration Time: 2026/09/23
Type: Observational study
Primary Sponsor: Jing'an District Central Hospital Of Shanghai
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342856
Published by HT Digital Content Services with permission from Health Daily Digest....